MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
Acurx Pharmaceuticals, Inc. (ACXP)
Acurx Pharmaceuticals, Inc. (ACXP)
source: myfinsight.com
Proceeds from issuance of
common stock in...
$3,106,246
Net cash provided by
financing activities
$3,106,246
Net
increase/(decrease) in cash
$1,698,713
Canceled cashflow
$1,407,533
Share-based compensation
$258,287
Accounts payable and
accrued expenses
$105,866
Share-based payments to
vendors
$61,000
Net cash used in
operating activities
-$1,407,533
Canceled cashflow
$425,153
Net loss
-$1,680,982
Prepaid expenses
$143,808
Other receivable
$7,896
Back